Preventing Chronic Disease | Association Between Prevalence of Chronic Obstructive Pulmonary Disease and Health-Related Quality of Life, South Carolina, 2011 - CDC
Association Between Prevalence of Chronic Obstructive Pulmonary Disease and Health-Related Quality of Life, South Carolina, 2011
Samuel Antwi, MPH; Susan E. Steck, MPH, PhD; Khosrow Heidari, MA, MS, MS
Suggested citation for this article:
Antwi S, Steck SE, Heidari K. Association Between Prevalence of Chronic Obstructive Pulmonary Disease and Health-Related Quality of Life, South Carolina, 2011. Prev Chronic Dis 2013;10:130192. DOI:http://dx.doi.org/10.5888/pcd10.130192
We investigated the prevalence of chronic obstructive pulmonary disease (COPD) in various population subgroups in South Carolina and examined associations between COPD and 4 core measures of health-related quality of life (HRQOL).
Data from 12,851 participants of the 2011 South Carolina Behavioral Risk Factor Surveillance System (BRFSS) were analyzed. COPD prevalence rates were age-adjusted to the 2000 standard US population. Logistic regression models were used to estimate adjusted odds ratios (AOR’s) and 95% confidence intervals (CIs).
The overall age-adjusted prevalence of self-reported diagnosis of COPD among community-dwelling adults in South Carolina in 2011 was 7.1% (standard error [SE] ±0.3). Prevalence of self-reported diagnosis of COPD was highest among women (8.9%; SE, ±0.5), those aged 65 years or older (12.9%; SE, ±0.5), current smokers (15.9%; SE, ±0.7), and those with low levels of education and income. Compared with community-dwelling adults without COPD, those with COPD were more likely to report fair or poor general health status (AOR, 3.97; 95% CI, 3.13–5.03), 14 or more physically unhealthy days (AOR, 2.10, 95% CI, 1.57–2.81), 14 or more mentally unhealthy days (AOR, 1.72; 95% CI, 1.21–2.43), and 14 or more days of activity limitation (AOR, 2.22; 95% CI, 1.53–3.22) within the previous 30 days.
COPD is a highly prevalent disease in South Carolina, especially among older people and smokers, and it is associated with poor HRQOL. Future work aimed at reducing risk factors may decrease the disease prevalence, and increasing early detection and improving access to appropriate medical treatments can improve HRQOL for those living with COPD.
Corresponding author: Samuel Antwi, MPH, Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina. 800 Sumter Street, Columbia SC, 29208. Telephone: 803-404-4035. E-Mail: ANTWI@email.sc.edu
Author Affiliations: Susan E. Steck, Arnold School of Public Health, University of South Carolina, Columbia South Carolina; Khosrow Heidari, Bureau of Community Health and Chronic Disease Prevention, South Carolina Department of Health & Environmental Control, Columbia, South Carolina.
- Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, Gold Executive Summary. Am J Respir Crit Care Med 2013;187(4):347–65. CrossRef PubMed
- Halpern MT, Stanford RH, Borker R. The burden of COPD in the SA: results from the Confronting COPD Survey. Respir Med 2003;97 Suppl. C:S81–9.CrossRef PubMed
- National Institutes of Health, National Heart, Lung, and Blood Institute. Morbidity and mortality: 2012 chartbook on cardiovascular, lung, and blood diseases. Bethesda (MD): National Heart, Lung, and Blood Institute, 2012.
- American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD 2004 V. New York (NY): American Thoracic Society; 2004. http://www.thoracic.org/clinical/copd-guidelines/index.php. Accessed August 20, 2012.
- Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2000;160(11):1683–9. CrossRef PubMed
- Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease among adults — United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61(46):938–43. PubMed
- Brown DW, Pleasants R, Ohar JA, Kraft M, Donohue JF, Mannino DM, et al. Health related quality of life and chronic obstructive pulmonary disease in North Carolina. North N Am J Med Sci 2010;2(2):60–5. PubMed
- Mannino DM. COPD: Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121(5, Suppl):121S–6S. CrossRefPubMed
- Jackson BE, Suzuki S, Coultas D, Singh KP, Bae S. chronic obstructive pulmonary disease and health-related quality of life in the 2009 Texas Behavioral Risk Factor Survey. Health Educ Behav 2013; 40(4):469-79. CrossRef PubMed
- Centers for Disease Control and Prevention. Measuring healthy days: population assessment of health-related quality of life. Atlanta (GA): Centers for Disease Control and Prevention; 2000. http://www.cdc.gov/hrqol/pdfs/mhd.pdf. Accessed August 20, 2012.
- Uzark K, King E, Spicer R, Beekman R, Kimball T, Varni JW. The clinical utility of health-related quality of life assessment in pediatric cardiology outpatient practice. Congenit Heart Dis 2013;8(3):211-8. CrossRef PubMed
- Harley C, Takeuchi E, Taylor S, Keding A, Absolom K, Brown J, et al. A mixed methods approach to adapting health-related quality of life measures for use in routine oncology clinical practice. Qual Life Res 2012;21(3):389–403. CrossRef PubMed
- Lopez-De Fede A, Mayfield-Smith K, Stewart J, Sudarshan N, Rodgers M, Sudduth D. Chronic obstructive pulmonary disorder (COPD) and SC Medicaid recipients: SFY 2010 Factsheet. Columbia (SC): Institute for Families in Society, University of South Carolina 2012. https://ifs.sc.edu/PRMM/Factsheets/2010/10COPD.pdf. Accessed August 20, 2012.
- Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System: 2011 survey data. Atlanta (GA): US Department of Health and Human Services: Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/brfss/annual_data/annual_2011.htm. Accessed August 20, 2013.
- Centers for Disease Control and Prevention. Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep 2012;61(22):410–3. PubMed
- Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System, 2011 Summary Data Quality Report. Atlanta (GA): Centers for Disease Control and Prevention; 2013. http://www.cdc.gov/brfss/pdf/2011_Summary_Data_Quality_Report.pdf. Accessed August 25, 2012.
- Brown DW, Balluz LS, Heath GW, Moriarty DG, Ford ES, Giles WH, et al. Associations between recommended levels of physical activity and health-related quality of life Findings from the 2001 Behavioral Risk Factor Surveillance System (BRFSS) survey. Prev Med 2003;37(5):520–8. CrossRefPubMed
- Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected US population. Healthy People 2000; Stat Notes 2001:1-9.
- Centers for Disease Control and Prevention. Public health strategic framework for COPD prevention. Atlanta (GA): Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/copd/pdfs/framework_for_copd_prevention.pdf. Accessed August 25, 2012.
- Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4(7):502–6. CrossRef PubMed
- Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765–73. CrossRef PubMed
- Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998–2009. National Center for Health Statistics data brief no. 63. Hyattsville (MD): US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2011. http://184.108.40.206/nchs/data/databriefs/db63.pdf. Accessed August 25, 2012.
- Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, et al. Gender and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176(12):1179–84. CrossRef PubMed
- Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (The BOLD Study): a population based prevalence study. Lancet 2007;370(9589):741–50. CrossRef PubMed
- Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008;134(4 Suppl):43S–56S. CrossRef PubMed
- Cafarella PA, Effing TW, Usmani ZA, Frith PA. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology 2012;17(4):627–38. CrossRef PubMed
- Mikkelsen RL, Middelboe T, Pisinger C, Stage K. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004;58(1):65–70. CrossRef PubMed
- Laurin C. Moullec1 G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 2012;185(9):918–23. CrossRef PubMed
- Walker AE. Multiple chronic diseases and quality of life: patterns emerging from a large national sample, Australia. Chronic Illn 2007;3(3):202–18.CrossRef PubMed
- Chen H-Y, Baumgardner DJ, Rice JP. Health-related quality of life among adults with multiple chronic conditions in the United States, Behavioral Risk Factor Surveillance System, 2007. Prev Chronic Dis 2011;8(1):A09 http://www.cdc.gov/pcd/issues/2011/jan/09_0234.htm. Accessed August 19, 2013. PubMed
No hay comentarios:
Publicar un comentario